TY - JOUR KW - Animals KW - Cytokines KW - Humans KW - Immunity, Innate KW - leprosy KW - Lipoproteins KW - Membrane Glycoproteins KW - Mice KW - Receptors, Cell Surface KW - Toll-Like Receptor 1 KW - Toll-Like Receptor 2 KW - Toll-Like Receptors AU - Krutzik SR AU - Ochoa MT AU - Sieling PA AU - Uematsu S AU - Ng Y AU - Legaspi A AU - Liu PT AU - Cole S AU - Godowski PJ AU - Maeda Y AU - Sarno E AU - Norgard MV AU - Brennan PJ AU - Akira S AU - Rea T AU - Modlin RL AB -

The expression and activation of Toll-like receptors (TLRs) was investigated in leprosy, a spectral disease in which clinical manifestations correlate with the type of immune response mounted toward Mycobacterium leprae. TLR2-TLR1 heterodimers mediated cell activation by killed M. leprae, indicating the presence of triacylated lipoproteins. A genome-wide scan of M. leprae detected 31 putative lipoproteins. Synthetic lipopeptides representing the 19-kD and 33-kD lipoproteins activated both monocytes and dendritic cells. Activation was enhanced by type-1 cytokines and inhibited by type-2 cytokines. In addition, interferon (IFN)-gamma and granulocyte-macrophage colony-stimulating factor (GM-CSF) enhanced TLR1 expression in monocytes and dendritic cells, respectively, whereas IL-4 downregulated TLR2 expression. TLR2 and TLR1 were more strongly expressed in lesions from the localized tuberculoid form (T-lep) as compared with the disseminated lepromatous form (L-lep) of the disease. These data provide evidence that regulated expression and activation of TLRs at the site of disease contribute to the host defense against microbial pathogens.

BT - Nature medicine C1 - http://www.ncbi.nlm.nih.gov/pubmed/12692544?dopt=Abstract DA - 2003 May DO - 10.1038/nm864 IS - 5 J2 - Nat. Med. LA - eng N2 -

The expression and activation of Toll-like receptors (TLRs) was investigated in leprosy, a spectral disease in which clinical manifestations correlate with the type of immune response mounted toward Mycobacterium leprae. TLR2-TLR1 heterodimers mediated cell activation by killed M. leprae, indicating the presence of triacylated lipoproteins. A genome-wide scan of M. leprae detected 31 putative lipoproteins. Synthetic lipopeptides representing the 19-kD and 33-kD lipoproteins activated both monocytes and dendritic cells. Activation was enhanced by type-1 cytokines and inhibited by type-2 cytokines. In addition, interferon (IFN)-gamma and granulocyte-macrophage colony-stimulating factor (GM-CSF) enhanced TLR1 expression in monocytes and dendritic cells, respectively, whereas IL-4 downregulated TLR2 expression. TLR2 and TLR1 were more strongly expressed in lesions from the localized tuberculoid form (T-lep) as compared with the disseminated lepromatous form (L-lep) of the disease. These data provide evidence that regulated expression and activation of TLRs at the site of disease contribute to the host defense against microbial pathogens.

PY - 2003 SP - 525 EP - 32 T2 - Nature medicine TI - Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. VL - 9 SN - 1078-8956 ER -